Left Atrial Appendage Closure
When left atrial appendage closure may be considered for stroke prevention in atrial fibrillation.
In non-valvular atrial fibrillation, many thrombi that lead to stroke arise in the left atrial appendage. Closing this structure with a catheter-delivered device may be considered for selected patients who have a clear indication for stroke prevention but cannot use long-term oral anticoagulation safely.
Assessment and Procedure
The decision requires careful comparison of thromboembolic risk, bleeding history, the reason anticoagulation is unsuitable and the feasibility of the procedure. Transoesophageal echocardiography or cardiac CT assesses appendage anatomy and excludes thrombus. The device is delivered across the atrial septum and positioned to seal the appendage.
Aftercare
Short-term antithrombotic treatment is still usually required and is tailored to bleeding risk. Follow-up imaging checks device position, residual leak and device-related thrombus. The procedure does not treat atrial fibrillation symptoms and is not a routine substitute for anticoagulants in patients who tolerate them well.
Stroke symptoms, severe breathlessness or persistent chest pain after the procedure require emergency assessment.
Patient Selection and Procedural Planning
The procedure is considered only when the expected diagnostic or therapeutic benefit is meaningful for the individual patient. Anatomy, prior imaging, symptoms, rhythm or haemodynamic findings, kidney function, bleeding and vascular risk, medicines and reasonable alternatives are reviewed before consent.
Technical Goals and Limitations
Procedural success requires a defined endpoint, but an immediate technical result does not guarantee permanent symptom relief or eliminate the underlying cardiovascular disease. Complex anatomy, previous procedures and associated disease can change technique, success probability and complication risk.
Risks and Safety
Potential risks vary by procedure and may include bleeding or vascular injury, cardiac perforation, rhythm or conduction disturbance, contrast or kidney effects, stroke, infection and the need for urgent additional treatment. The treating team explains the risks that are specifically relevant to the planned approach.
Recovery and Follow-up
Written instructions should cover access-site or wound care, medicines, driving, work, physical activity and warning signs. Follow-up confirms the procedural endpoint, symptom response and any required imaging or rhythm monitoring. Never stop antithrombotic or rhythm medicine without a procedure-specific plan.
Questions to Ask Before the Procedure
- What precise problem is the procedure intended to solve?
- What alternatives are reasonable in my situation?
- What is the expected success rate and the most relevant personal risk?
- What follow-up and medicines will be needed afterwards?
Medical Information Note
This information supports, but does not replace, the individual consent discussion with the treating cardiovascular team.